{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T11:22:07Z","timestamp":1793013727625,"version":"4.5.0"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,5]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>To evaluate the effect of antenatal influenza vaccination on all-cause severe infant pneumonia, we performed pooled analysis of 3 randomized controlled trials conducted in Nepal, Mali and South Africa.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>The trials were coordinated from the planning phase. The follow-up period was 0\u20136 months postpartum in Nepal and Mali and 0\u201324 weeks in South Africa. Pregnant women with gestational age 17\u201334 weeks in Nepal, \u226528 weeks in Mali and 20\u201336 weeks in South Africa were enrolled. Trivalent inactivated influenza vaccine (IIV) was compared with either saline placebo (Nepal and South Africa) or quadrivalent meningococcal conjugate vaccine (Mali). In South Africa, cases were hospitalized and were therefore considered to have severe pneumonia. In Nepal and Mali, severe infant pneumonia diagnosis was based on the WHO Integrated Management of Childhood Illness definition.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>A total of 10,002 mothers and 9801 live-born eligible infants were included in the present analysis. There was a 31% lower incidence rate of severe pneumonia in the IIV group compared with the control group in Nepal [incidence rate ratio (IRR): 0.69; 95% CI: 0.50\u20130.94; Table 1]. In South Africa, there was a 43% lower incidence rate of severe pneumonia in the IIV group versus the control group (IRR: 0.57; 95% CI: 0.33\u20131.0). There was no difference in incidence rates between the IIV group and the control group in Mali. Overall, incidence rate of severe pneumonia was 20% lower in the IIV group compared with the control group (IRR: 0.80; 95% CI: 0.66\u20130.99; <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.04). Protection was highest in the high influenza circulation period (IRR: 0.44; 95% CI: 0.23\u20130.84).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Maternal influenza immunization may reduce severe pneumonia episodes among infants\u2014particularly those too young to be completely vaccinated against <jats:italic toggle=\"yes\">Streptococcus pneumoniae<\/jats:italic> and influenza.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/inf.0000000000001914","type":"journal-article","created":{"date-parts":[[2018,2,14]],"date-time":"2018-02-14T17:58:11Z","timestamp":1518631091000},"page":"436-440","source":"Crossref","is-referenced-by-count":61,"title":["Maternal Influenza Immunization and Prevention of Severe Clinical Pneumonia in Young Infants"],"prefix":"10.1097","volume":"37","author":[{"given":"Saad B.","family":"Omer","sequence":"first","affiliation":[{"name":"Hubert Department of Global Health"},{"name":"Department of Epidemiology, Emory University Rollins School of Public Health, Atlanta, Georgia"},{"name":"Emory Vaccine Center, Atlanta, Georgia"},{"name":"Department of Pediatrics, Emory University School of Medicine and Children\u2019s Healthcare of Atlanta, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dayna R.","family":"Clark","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Emory University Rollins School of Public Health, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anushka R.","family":"Aqil","sequence":"additional","affiliation":[{"name":"Hubert Department of Global Health"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milagritos D.","family":"Tapia","sequence":"additional","affiliation":[{"name":"Centre pour le D\u00e9veloppement des Vaccins, Bamako, Mali"},{"name":"Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta C.","family":"Nunes","sequence":"additional","affiliation":[{"name":"Medical Research Council: Respiratory and Meningeal Pathogens Research Unit, University of the Witwatersrand, Johannesburg, South Africa"},{"name":"Department of Science and Technology, Vaccine-Preventable Diseases Section, National Research Foundation, Johannesburg, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoko","family":"Kozuki","sequence":"additional","affiliation":[{"name":"Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark C.","family":"Steinhoff","sequence":"additional","affiliation":[{"name":"Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland"},{"name":"Cincinnati Children\u2019s Hospital Global Health Center, Cincinnati, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shabir A.","family":"Madhi","sequence":"additional","affiliation":[{"name":"Medical Research Council: Respiratory and Meningeal Pathogens Research Unit, University of the Witwatersrand, Johannesburg, South Africa"},{"name":"Department of Science and Technology, Vaccine-Preventable Diseases Section, National Research Foundation, Johannesburg, South Africa"},{"name":"National Institute for Communicable Diseases, The National Health Laboratory Service, Centre for Vaccines and Immunology, Johannesburg, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niteen","family":"Wairagkar","sequence":"additional","affiliation":[{"name":"Bill & Melinda Gates Foundation, Seattle, Washington."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230912","doi-asserted-by":"crossref","first-page":"e1001161","DOI":"10.1371\/journal.pmed.1001161","article-title":"Monitoring the introduction of pneumococcal conjugate vaccines into West Africa: design and implementation of a population-based surveillance system.","volume":"9","author":"Mackenzie","year":"2012","journal-title":"PLoS Med"},{"key":"R2-20230912","doi-asserted-by":"crossref","first-page":"e69","DOI":"10.1097\/INF.0000000000001009","article-title":"Etiology of pneumonia in a pediatric population with high pneumococcal vaccine coverage: a prospective study.","volume":"35","author":"Berg","year":"2016","journal-title":"Pediatr Infect Dis J"},{"issue":"Suppl 3","key":"R3-20230912","doi-asserted-by":"crossref","first-page":"C9","DOI":"10.1016\/j.vaccine.2009.06.007","article-title":"Pneumococcal pneumonia and influenza: a deadly combination.","volume":"27","author":"Klugman","year":"2009","journal-title":"Vaccine"},{"key":"R4-20230912","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.3201\/eid1408.071313","article-title":"Deaths from bacterial pneumonia during 1918-19 influenza pandemic.","volume":"14","author":"Brundage","year":"2008","journal-title":"Emerg Infect Dis"},{"key":"R5-20230912","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1056\/NEJMoa0708630","article-title":"Effectiveness of maternal influenza immunization in mothers and infants.","volume":"359","author":"Zaman","year":"2008","journal-title":"N Engl J Med"},{"key":"R6-20230912","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1056\/NEJMoa1401480","article-title":"Influenza vaccination of pregnant women and protection of their infants.","volume":"371","author":"Madhi","year":"2014","journal-title":"N Engl J Med"},{"key":"R7-20230912","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/S1473-3099(16)30054-8","article-title":"Maternal immunisation with trivalent inactivated influenza vaccine for prevention of influenza in infants in Mali: a prospective, active-controlled, observer-blind, randomised phase 4 trial.","volume":"16","author":"Tapia","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"R8-20230912","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/S1473-3099(17)30252-9","article-title":"Year-round influenza immunisation during pregnancy in Nepal: a phase 4, randomised, placebo-controlled trial.","volume":"17","author":"Steinhoff","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"R10-20230912","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/S0140-6736(13)60222-6","article-title":"Global burden of childhood pneumonia and diarrhoea.","volume":"381","author":"Walker","year":"2013","journal-title":"Lancet"},{"key":"R11-20230912","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1097\/INF.0000000000000478","article-title":"Epidemiology of viral-associated acute lower respiratory tract infection among children <5 years of age in a high HIV prevalence setting, South Africa, 2009-2012.","volume":"34","author":"Cohen","year":"2015","journal-title":"Pediatr Infect Dis J"},{"key":"R12-20230912","doi-asserted-by":"crossref","first-page":"3801","DOI":"10.1016\/j.vaccine.2015.05.077","article-title":"Three randomized trials of maternal influenza immunization in Mali, Nepal, and South Africa: methods and expectations.","volume":"33","author":"Omer","year":"2015","journal-title":"Vaccine"},{"key":"R13-20230912","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/cix497","article-title":"Efficacy of maternal influenza vaccination against all-cause lower respiratory tract infection hospitalizations in young infants: Results from a randomized controlled trial.","author":"Nunes","year":"2017","journal-title":"Clin Infect Dis"},{"key":"R14-20230912","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/S0140-6736(05)71876-6","article-title":"Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial.","volume":"365","author":"Cutts","year":"2005","journal-title":"Lancet"},{"key":"R16-20230912","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1086\/341462","article-title":"Lethal synergism between influenza virus and Streptococcus pneumoniae: characterization of a mouse model and the role of platelet-activating factor receptor.","volume":"186","author":"McCullers","year":"2002","journal-title":"J Infect Dis"},{"key":"R17-20230912","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/nm1765","article-title":"Inhibition of pulmonary antibacterial defense by interferon-gamma during recovery from influenza infection.","volume":"14","author":"Sun","year":"2008","journal-title":"Nat Med"},{"key":"R18-20230912","doi-asserted-by":"crossref","first-page":"293","DOI":"10.2105\/AJPH.28.3.293","article-title":"A study of a type I pneumococcus epidemic at the state hospital at Worcester, Mass.","volume":"28","author":"Smillie","year":"1938","journal-title":"Am J Public Health Nations Health"},{"key":"R19-20230912","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1086\/313772","article-title":"Severe pneumococcal pneumonia in previously healthy children: the role of preceding influenza infection.","volume":"30","author":"O\u2019Brien","year":"2000","journal-title":"Clin Infect Dis"},{"key":"R20-20230912","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1093\/infdis\/jit003","article-title":"Combined effects of antenatal receipt of influenza vaccine by mothers and pneumococcal conjugate vaccine receipt by infants: results from a randomized, blinded, controlled trial.","volume":"207","author":"Omer","year":"2013","journal-title":"J Infect Dis"},{"key":"R21-20230912","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1097\/INF.0b013e3182a26752","article-title":"Effectiveness of pneumococcal conjugate vaccine in infants by maternal influenza vaccination status.","volume":"32","author":"van Santen","year":"2013","journal-title":"Pediatr Infect Dis J"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00006454-201805000-00012","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T22:34:40Z","timestamp":1694558080000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006454-201805000-00012"}},"subtitle":["Analysis of Randomized Controlled Trials Conducted in Nepal, Mali and South Africa"],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":19,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000001914","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]}}}